期刊文献+

加替沙星与左氧氟沙星注射液治疗急性淋菌性泌尿生殖道感染的对照研究 被引量:2

Randomized controlled study on gatifloxacin and levofloxacin injectionin the treatment of acute gonococcal urinary and reproductive tract infections
下载PDF
导出
摘要 目的 :加替沙星注射液在治疗急性淋菌性泌尿生殖道感染中的有效性和安全性。方法 :采用随机双盲对照试验 ,以左氧氟沙星为对照药物 ,共治疗急性淋菌性泌尿生殖道感染 38例 ,加替沙星组和左氧氟沙星组各 19例。治疗方案均为静脉输注每次 0 .2 g ,一日两次 ,疗程 7~ 14天。结果 :试验组临床治愈率、有效率和淋菌清除率均为 10 0 % ,对照组分别为 96 .2 %、10 0 %和 10 0 %。对合并的支原体、衣原体感染的清除率试验组为 10 0 % ,而左氧氟沙星组为 85 .71%和 10 0 % ,两组无统计学差异 (P >0 .0 5 )。两组均无明显不良反应发生。结论 :加替沙星治疗急性淋菌性泌尿生殖道感染的有效性和安全性与左氧氟沙星相似。 Objective:To study the efficacy and safety of gatifloxacin injection in the treatment of acute gonococcal urinary and reproductive tract infections.Methods:Taken levofloxacin as control,a double-blinded,randomized-controlled clinical trial was conducted.A total of 38 patients were enrolled (19 in trial group,19 in control group).The regimens were as follows:Either gatifloxacin or levofloxacin 0.2g,iv,twice a day for 7~14 days.Results:The cure rate,effective rate and bacterial clearance rate for trial groups were 100%,and those for control groups were 96.2%,100% and 100%,respectively.The mycoplasma and chlamydia clearance rates for trial groups were 100%,and those for control groups were 85.71% and 100% respectively.Statistic analysis did not show significant differences between the two groups ( P >0.05).No adverse effects were observed in both groups.Conclusion:The efficacy and safety of gatifloxacin are similar to those of levofloxacin in the treatment of acute gonococcal urinary and reproductive tract infections.
出处 《重庆医科大学学报》 CAS CSCD 2004年第6期798-799,810,共3页 Journal of Chongqing Medical University
关键词 加替沙星 左氧氟沙星 泌尿生殖道感染 随机对照 临床研究 Gatifloxacin Levofloxacin Urinary and reproductive infections Randomized controlled Clinical trial
  • 相关文献

参考文献4

  • 1朱曼,王睿.第四代氟喹诺酮类抗菌药——加替沙星[J].中国临床药理学与治疗学,2001,6(4):377-381. 被引量:71
  • 2Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM 1155, a new 8 methoxy quinolone[J]. J Antimicrob Chemother, 1995; 36: 293 - 307.
  • 3Hosaka M. Antibacterial property and clinical effect of gatifloxacin, a novel quinolone antibacterial agent [ J ]. Nippon Yakurigaku Zasshi, 2003; 121: 447 - 456.
  • 4Perry CM, Ormrod D, Hurst M, et al. Gatifloxacin: a review of its use in the management of bacterial infections [J].Drugs, 2002; 62:169 - 207.

二级参考文献21

  • 1赵树清,王金生.新型氟喹诺酮抗菌剂——AM—1155[J].中国医药情报,1996,2(4):249-252. 被引量:4
  • 2JLM. Oral and iv formulations of gatifoxacin cleared for US. market. Am J Health-Syst Pharm, 2000; 57:204
  • 3Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemther,1995; 36:293
  • 4Tomioka H, Saito H, Sato K. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin and ofloxacin. Antimicrob Agents Chemother, 1993;37:1259
  • 5Takei M, Fukuda H, Yasue T, et al. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian typeⅡ topoisomerase. Antimicro Agents Chemother, 1998;42:2678
  • 6Wakabayshi E, Mitsuhashi S. In vitro antibacterial activitiy of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother, 1994;38:594
  • 7Fukuda H, Hori S, Hiramatsu K. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone- resistants mutants and the norA transformant of staphylococcus aureus. Antimicrob Agents Chemother, 1998;42:1917
  • 8Deguchi T, Yasuda M, Nakano M, et al. Comparision of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Chemotherapy, 1997;43:239
  • 9Appelbaum PC. Quinolone activity against anaerobes. Drugs, 1999;58 (suppl 2):60
  • 10Ednie LM, Jacobs M, Appelaum PC. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob Agents Chemother, 1998;42:2459

共引文献70

同被引文献70

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部